Skip to main content

Early value dossiers for medical technologies

The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) sets priorities in 2024 health reform

On October 18, 2023, the Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) announced that its budget would increase by 3.9 billion to 25.8 billion euros (by 18%) in the coming year. 1.1 billion euros from the budget will be allocated for the health care reform, which will be implemented as part of the financial equalization.

The most significant part of this budget will be provided to the federal states and sickness funds to strengthen the private sector and structural reforms in hospitals. Additional funds will also be allocated for prevention programs and digitalization.

An additional 400 million euros will be allocated for care measures. This continues the improvements of the major care reform - such as higher salaries for nursing staff, training subsidies for first-time trainees and job changers, and support for caring relatives. 43.6 million euros will be assigned for the measures in 24-hour care.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.